- US12358986utility2025Anti-cancer Combination Therapies Comprising CTLA-4 and PD-1 Blocking Agents0 cites
- US12350270utility2025Antimalarial Agents0 cites
- US12351630utility2025PD1 And/or LAG3 Binders0 cites
- US12344595utility20252-amino-n-phenyl-nicotinamides as NAV1.8 Inhibitors0 cites
- US12344616utility2025Factor Xia Inhibitors0 cites
- US12344670utility2025Anti-ilt4 Antibodies and Antigen-binding Fragments0 cites
- US12331018utility2025Pyrrolidine Orexin Receptor Agonists0 cites
- US12331022utility2025Spiropiperidine Allosteric Modulators of Nicotinic Acetylcholine Receptors0 cites
- US12331044utility2025Inhibitors of Histone Deacetylase Useful for the Treatment or Prevention of HIV Infection0 cites
- US12319735utility2025Co-formulations of Anti-lag3 Antibodies and Anti-pd-1 Antibodies0 cites
- US12311021utility2025Replication-competent Attenuated Chimeric VSV Vectors Encoding Immunogenic Sars-cov-2 Spike Proteins0 cites
- US12310945utility2025Cyclohexylglycine Derivatives as Selective Cytotoxic Agents0 cites
- US12310953utility2025Pharmaceutical Formulations for the Treatment of Migraine0 cites
- US12312332utility2025Heteroaryl Pyrrolidine and Piperidine Orexin Receptor Agonists0 cites
- US12306082utility2025Apparatus and Method for Monitoring and Recording Disintegration Times for Pharmaceutical Products0 cites
- US12303460utility2025Moisture Protection Features for a Bottle for Storing Solid Pharmaceutical Products and Methods of Making Same0 cites
- US12304899utility2025Factor XI Activation Inhibitors0 cites
- US12295998utility2025Enhancing Immunogenicity of Streptococcus Pneumoniae Polysaccharide-protein Conjugates0 cites
- US12297208utility2025Small Molecule Inhibitors of KRAS G12C Mutant0 cites